Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03802864 · ClinicalTrials.gov registry record · Phase 4
Post-operative Pain Control of Testicular Sperm Extraction Using Liposomal Bupivacaine
A Phase 4 study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT03802864 is a Phase 4 study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 50 participants.
The verdict
NCT03802864, a Phase 4 study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
The study is a drug trial comparing the post-operative pain control provided by liposomal bupivacaine (a local anesthetic) against standard bupivacaine (a different formulation of the local anesthetic) for men undergoing testicular sperm extraction.
Interventions
- DRUG Liposomal Bupivacaine
- DRUG Standard Bupivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2019-02-04 |
| Est. Completion | 2020-01-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03802864
The ClinicalTrials.gov registry entry for NCT03802864 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Liposomal Bupivacaine is the first listed.
NCT03802864 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03802864 about?
NCT03802864 is a clinical study titled "Post-operative Pain Control of Testicular Sperm Extraction Using Liposomal Bupivacaine". The study is a drug trial comparing the post-operative pain control provided by liposomal bupivacaine (a local anesthetic) against standard bupivacaine (a different formulation of the local anesthetic) for men undergoing testicular sperm extraction.
What is the current status of trial NCT03802864?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2019-02-04. Estimated completion is 2020-01-30.
What interventions are being tested in trial NCT03802864?
The interventions under investigation include: Liposomal Bupivacaine (DRUG), Standard Bupivacaine (DRUG).
Who is sponsoring clinical trial NCT03802864?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.